BioCentury
ARTICLE | Company News

Pharmacopeia, NV Organon deal

January 31, 2000 8:00 AM UTC

Organon, a business unit of Akzo Nobel N.V. (Arnhem, the Netherlands), and PCOP will develop small molecule antagonists of interleukin-8. Organon will fund lead optimization at PCOP and will develop ...